Skip to main content
Advertising

Originally published Wednesday, December 26, 2012 at 11:26 AM

  • Share:
             
  • Comments (0)
  • Print

News Summary: Anticlot drug Eliquis OK'd in Japan

THIRD APPROVAL: Regulators in Japan have approved anticlotting drug called Eliquis, a potential blockbuster from Bristol-Myers Squibb and Pfizer. It's already on sale in Canada and the European Union.

The Associated Press

Most Popular Comments
Hide / Show comments
No comments have been posted to this article.
Start the conversation >

advertising

THIRD APPROVAL: Regulators in Japan have approved anticlotting drug called Eliquis, a potential blockbuster from Bristol-Myers Squibb and Pfizer. It's already on sale in Canada and the European Union.

THIRD TRY: The U.S. Food and Drug Administration has twice postponed a decision on Eliquis, first saying it needed more time and then requiring additional data. That was submitted in September, and the FDA now is set to rule by March 17.

THIRD DRUG: Two similar drugs already on sale have a big head start - Pradaxa, from Germany's Boehringer Ingelheim, and Xarelto, from partners Johnson & Johnson and Bayer Healthcare.

News where, when and how you want it

Email Icon


Advertising